Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
PsyPost on MSN17d
Nicotinamide trial for Alzheimer’s disease shows no clear benefit in reducing tau proteinsA recent study published in Neurology explored whether high doses of nicotinamide, a derivative of vitamin B3, could reduce a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback